NEXQ builds patent-pending hybrid-quantum software for diagnostic-support and treatment-planning review.
Last updated September 1, 2026
AI crawler reads
2requests
1companies- Anthropic2
- Profile
- 2
- Controversies
- 0
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
NEXQ is a company that builds patent-pending hybrid-quantum software designed to stand beside clinicians as scans move toward diagnosis-support context and treatment-planning review. It offers products like LiMiQ and TumorQ, which are planned or pilot-governed software layers for diagnostic evidence and oncology workflows.
History
NEXQ builds patent-pending hybrid-quantum software designed to stand beside clinicians as scans move toward diagnosis-support context and treatment-planning review. It offers LiMiQ, a reviewable evidence layer around diagnostic-support output, and TumorQ, a pilot-governed oncology software layer powered by patent-pending hybrid-quantum algorithms.
Products and positioning
LiMiQ
LiMiQ is the reviewable evidence layer NEXQ is building around diagnostic-support output: source context, confidence, limitations, reviewer notes, and professional sign-off before a finding becomes part of a care conversation.
TumorQ
TumorQ is NEXQ's pilot-governed oncology software layer powered by patent-pending hybrid-quantum algorithms for the moments when time, imaging context, molecular findings, diagnostic evidence, and treatment options cannot stay scattered.
Sources5 sources
Cite this profile: Cite the canonical profile. /brand-wiki/nexq · Editorial policy · How profiles are compiled